跳至主要内容
临床试验/IRCT20200404046947N1
IRCT20200404046947N1已完成2 期

Study of Methylprednisolone effects on treatment and clinical symptoms and laboratory signs of Iranian ?COVID-19 patients: a clinical trial study

Tehran University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • COVID-19 patient confirmed by positive PCR ?test for SARS-CoV-2 or abnormal CT scan finding (bilateral, sub pleural, peripheral ground glass ?opacities), Blood oxygen saturation <93%, Respiratory Rate >30 breaths/minute, before connecting to ventilator and intubation.?

排除标准

  • Patients with uncontrolled type I diabetes, blood pressure, positive pro-calcitonin, active infection, and ?taking any immune-suppressor agents, will exclude from the study.?

研究者

相似试验